Spruce Point Takes Aim at Nuvei: What Should Investors Do With the Stock Today?

Despite its recent sharp decline caused by a short-seller report, Nuvei stock is a buy.

| More on:

Shares of Nuvei (TSX:NVEI)(NASDAQ:NVEI) fell as much as 55% on December 8 after Spruce Point took aim at the Montreal-based payment processor. The stock has recovered some of its losses since then but is still far from the price it was at before the short-seller attack.

What the report said

After conducting a financial analysis, Spruce Point came to the conclusion that Nuvei has hidden failed business models, a lack of organic growth, and fraudulent activities.

The short-seller also questioned the recent acquisitions of the company and accused it of a lack of transparency in the disclosure of its financial results.

Spruce Point issued a “strong sell” notice on the stock and said it believed Nuvei stock could fall as much as 60%.

The New York firm had to clarify that it held a short position in Nuvei and held derivative securities that could benefit from the drop in its share price.

Nuvei has dismissed the short-seller accusations

Meanwhile, in a statement released the night after the report, Nuvei dismissed Spruce Point accusations and reiterated its financial forecast.

“The personal attacks on Nuvei executives made by the short-seller appear to have been made to distract from the company’s achievements and progress,” it stated in a news release. “The short-seller admits that it stands to profit significantly from Nuvei’s stock price decline, at the expense of Nuvei’s shareholders, customers and employees.”

In the third quarter, Nuvei made a profit, with revenue increasing 96% year over year to $183.9 million, while payments volume increased 88% to $21.6 billion.

Management refutes Spruce Point’s financial claims

Two weeks after the publication of a report by short-selling firm Spruce Point Capital that halved Nuvei’s share price, the management of this Montreal electronic payment processor replied by refuting 20 of the 21 financial allegations in the report.

This management response is very detailed and compelling, according to James Fotheringham, analyst at BMO Capital Markets. After a thorough review of Spruce Point’s allegations and management’s responses, the analyst recommended that investors looking for reasonably priced growth stocks buy Nuvei stock, for which it maintains a target price of $114.

Management does not rule out the possibility of suing the authors of the report. Such an announcement would likely be a catalyst for the stock.

Management is also reviewing the share-buyback program by the company as well as by its officers. As well as being a very attractive transaction, this would send a strong signal from management.

Nuvei is also considering holding an Investor Day in the short term, during which it will provide an update on its financial performance. 

Nuvei stock is oversold

Investors might wonder what they should do with Nuvei stock today. Despite its recent sharp decline, Nuvei is a buy. Analysts remain largely bullish on the stock. 

Based on the third-quarter and year-to-date results, the company is growing at a decent pace, and the international payments segment has significant growth potential in the coming years.

If the market decides the pullback is overdone, Nuvei stock could deliver big gains for new investors in the days and weeks to come. It’s one of the best Canadian tech stocks to buy today.

Fool contributor Stephanie Bedard-Chateauneuf owns shares of Nuvei Corporation. The Motley Fool owns and recommends Nuvei Corporation.

More on Tech Stocks

man in bowtie poses with abacus
Dividend Stocks

What the Average Canadian TFSA Looks Like at Age 50

See what the average Canadian TFSA looks like at age 50 and how CNR, Constellation Software, and VFV could support…

Read more »

Senior uses a laptop computer
Dividend Stocks

A Canadian Dividend Stock Down 35% to Buy and Hold for Retirement

Rogers’ 13% dip has pushed its yield above 4%, and management expects a big jump in free cash flow.

Read more »

A patient takes medicine out of a daily pill box.
Tech Stocks

1 Undervalued Canadian Stock to Buy and Hold Forever

This small-cap healthcare software stock keeps winning long-term contracts and just got a governance stamp of approval.

Read more »

crisis concept, falling stairs
Tech Stocks

1 Canadian Stock Down 45% I’d Buy and Hold Now

Constellation Software’s 45% plunge looks scary, but its revenue and cash flow are still growing fast.

Read more »

The TFSA is a powerful savings vehicle for Canadians who are saving for retirement.
Dividend Stocks

3 Canadian Stocks Well-Suited for a Long-Term Buy-and-Hold TFSA

A simple TFSA mix of Shopify, CN Rail, and Royal Bank aims to compound for decades while keeping every gain…

Read more »

Women's fashion boutique Aritzia is a top stock to buy in September 2022.
Tech Stocks

What Are the Best High-Growth Canadian Stocks to Buy Now?

Three Canadian growth stocks look compelling, but they’re priced for success, so gradual buying and position sizing matter.

Read more »

Couple working on laptops at home and fist bumping
Tech Stocks

How Much Canadians Usually Have in an RRSP by Age 45

See how your RRSP compares at age 45, and why a growth stock like CGI, powered by Q2 earnings, could…

Read more »

Digital background depicting innovative technologies in quantum computing, (AI) artificial systems, neural interfaces and internet machine learning technologies
Tech Stocks

1 Impressive Quantum Computing ETF I’m Strongly Considering Right Now

Quantum computing could be the future of technology, but it's too early to pick winners.

Read more »